VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MKL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MKLMarkel Corporation
$1940.17$24.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMKLFinancials

Markel Corporation (MKL) Income Statement

30Y historyFree accessUpdated daily

Revenue has oscillated between roughly $3.3B and $5.2B with a 2026Q3 combined ratio of 90.8% and a 2026Q1 combined ratio of 107.7%, indicating underwriting results that are highly uneven quarter to quarter.

Income StatementBalance SheetCash FlowRatios

MKL Income Statement

Annual statement

MKL Income Statement

Markel Corporation (MKL) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue17.13B16.59B16.75B15.71B11.81B12.92B9.64B9.52B6.95B6.06B5.61B5.37B5.13B4.32B3B2.63B2.23B2.07B1.98B2.48B2.52B2.2B2.26B2.09B1.77B1.4B1.09B524.32M426M419M366.7M
Revenue Growth %7.27%-0.96%6.6%33.02%-8.55%34.02%1.26%36.98%14.59%8.09%4.48%4.6%18.75%44.1%14.07%18.18%7.54%4.69%-20.4%-1.42%14.49%-2.74%8.13%18.17%26.68%27.68%108.74%23.08%1.67%14.26%6.72%
Medical Costs & Claims5.85B5.08B7.48B7.63B8.41B7.03B6.26B4.67B4.3B4.22B3.25B2.75B2.92B2.34B1.58B1.72B1.37B992.86M1.27B1.85B1.9B1.95B1.98B1.85B1.6B1.5B1.07B440.33M328.18M120.1M0
Medical Cost Ratio %34.15%30.62%44.64%48.57%71.17%54.38%64.91%49.03%61.94%69.56%57.91%51.26%56.88%54.09%52.81%65.52%61.66%47.98%64.2%74.62%75.44%88.64%87.61%88.64%90.48%107.36%97.82%83.98%77.04%28.66%0%
Gross Profit11.28B11.51B9.27B8.08B3.41B5.89B3.38B4.85B2.64B1.85B2.36B2.62B2.21B1.98B1.42B906.79M853.27M1.08B707.56M630.35M618.57M249.84M280.26M237.67M168.48M-102.87M23.86M83.99M97.82M298.9M366.7M
Gross Margin %65.85%69.38%55.36%51.43%28.83%45.62%35.09%50.97%38.06%30.44%42.09%48.74%43.12%45.91%47.19%34.48%38.34%52.02%35.8%25.38%24.56%11.36%12.39%11.36%9.52%-7.36%2.18%16.02%22.96%71.34%100%
Gross Profit Growth %-24.12%14.75%137.29%-42.21%74.25%-30.3%83.46%43.27%-21.83%-9.77%18.26%11.53%40.18%56.13%6.27%-20.73%52.14%12.25%1.9%147.59%-10.86%17.92%41.07%263.78%-531.08%-71.59%-14.14%-67.27%-18.49%6.72%
Operating Expenses8.91B8.78B5.64B5.43B3.56B2.76B2.38B2.57B2.65B1.76B1.73B1.88B1.77B1.62B1.1B716.59M557.76M877.83M867.39M58.4M65.17M63.84M56.22M56.09M50.78M79.33M75.67M30.55M22.44M20.1M8M
OpEx / Revenue %52.05%52.91%33.64%34.54%30.11%21.39%24.71%26.96%38.17%29%30.86%34.92%34.54%37.54%36.79%27.25%25.06%42.42%43.88%2.35%2.59%2.9%2.49%2.68%2.87%5.68%6.91%5.83%5.27%4.8%2.18%
Depreciation & Amortization172.86M347.92M342.36M319.73M309.45M336.39M307.07M269.24M227.85M203.87M194.15M200.99M203.58M190.07M87.33M70.57M53.59M31.17M31.19M30.53M34.04M36.34M31.34M39.26M28.23M41.91M32.4M12.86M7.3M7.3M10.9M
Combined Ratio %86.21%83.53%78.28%83.11%101.28%75.77%89.62%75.99%100.11%98.56%88.77%86.18%91.42%91.63%89.6%92.77%86.72%90.4%108.09%76.97%78.03%91.55%90.1%91.32%93.35%113.04%104.73%89.81%82.3%33.46%2.18%
Operating Income2.36B2.73B3.64B2.65B-151.57M3.13B1B2.29B-7.86M87.3M629.92M742.11M440.38M361.74M312.05M190.2M295.51M198.64M-159.83M571.96M553.4M186M224.04M181.58M117.69M-182.2M-51.81M53.44M75.39M278.8M358.7M
Operating Margin %13.79%16.47%21.72%16.89%-1.28%24.23%10.38%24.01%-0.11%1.44%11.23%13.82%8.58%8.37%10.4%7.23%13.28%9.6%-8.09%23.03%21.97%8.45%9.9%8.68%6.65%-13.04%-4.73%10.19%17.7%66.54%97.82%
Operating Income Growth %--24.88%37.08%1850.86%-104.84%212.84%-56.23%29200.04%-109%-86.14%-15.12%68.52%21.74%15.92%64.07%-35.64%48.77%224.28%-127.94%3.35%197.53%-16.98%23.38%54.29%164.6%-251.69%-196.94%-29.11%-72.96%-22.27%7.04%
EBITDA2.54B3.08B3.98B2.97B157.88M3.47B1.31B2.56B219.99M291.17M824.07M943.09M643.96M551.81M399.38M260.77M349.1M229.81M-128.64M602.49M587.44M222.34M255.38M220.85M145.92M-140.28M-19.41M66.3M82.68M286.1M369.6M
EBITDA Margin %14.8%18.57%23.76%18.92%1.34%26.83%13.56%26.84%3.17%4.8%14.69%17.56%12.54%12.76%13.31%9.92%15.69%11.11%-6.51%24.26%23.32%10.11%11.29%10.56%8.24%-10.04%-1.77%12.64%19.41%68.28%100.79%
Interest Expense204.16M205.91M204.3M185.08M196.06M183.58M177.58M171.69M154.21M132.45M129.9M118.3M117.44M114M92.76M86.25M73.66M53.97M48.21M56.25M65.17M63.84M56.22M51.96M40.1M48.65M52.35M25.15M20.41M20.1M8M
Non-Operating Income-116.79M-205.91M-204.3M-185.08M-196.06M-183.58M-177.58M-171.69M-154.21M-132.45M-129.9M-118.3M-117.44M-114M-92.76M-86.25M-73.66M-53.97M-48.21M-56.25M-65.17M-63.84M-56.22M-51.96M-40.1M-48.65M-52.35M-25.15M-20.41M258.7M350.7M
Pretax Income2.33B2.73B3.64B2.65B-151.57M3.13B1B2.29B-7.86M87.3M629.92M742.11M440.38M361.74M312.05M190.2M295.51M198.64M-159.83M571.96M553.4M186M224.04M181.58M117.69M-182.2M-51.81M53.44M75.39M66.3M37M
Pretax Margin %13.6%16.47%21.72%16.89%-1.28%24.23%10.38%24.01%-0.11%1.44%11.23%13.82%8.58%8.37%10.4%7.23%13.28%9.6%-8.09%23.03%21.97%8.45%9.9%8.68%6.65%-13.04%-4.73%10.19%17.7%15.82%10.09%
Income Tax495.98M580.3M790.29M552.62M-48.21M683.96M168.68M486.35M122.5M-313.46M169.48M152.96M116.69M77.9M53.8M41.71M27.78M-3.78M-101.39M166.29M160.9M38.09M58.63M58.11M42.37M-56.48M-24.21M12.83M18.09M15.9M-9.7M
Effective Tax Rate %21.29%21.24%21.73%20.82%31.81%21.85%16.86%21.28%-1559.49%-359.08%26.9%20.61%26.5%21.53%17.24%21.93%9.4%-1.9%63.44%29.07%29.07%20.48%26.17%32%36%31%46.74%24%24%23.98%-26.22%
Net Income1.79B2.11B2.75B2B-216.28M2.42B816.03M1.79B-128.18M395.27M455.69M582.77M321.18M281.02M253.38M142.03M266.79M201.64M-58.77M405.67M392.5M147.91M165.41M123.48M75.32M-125.72M-27.59M40.61M57.29M50.4M46.7M
Net Margin %10.47%12.7%16.4%12.7%-1.83%18.76%8.47%18.81%-1.84%6.52%8.12%10.85%6.26%6.5%8.45%5.4%11.99%9.74%-2.97%16.34%15.58%6.72%7.31%5.9%4.26%-9%-2.52%7.75%13.45%12.03%12.74%
Net Income Growth %-13.79%-23.3%37.62%1022.92%-108.93%196.94%-54.42%1496.84%-132.43%-13.26%-21.81%81.45%14.29%10.91%78.41%-46.77%32.31%443.11%-114.49%3.35%165.36%-10.58%33.96%63.93%159.92%-355.63%-167.94%-29.11%13.68%7.92%35.36%
EPS (Diluted)144.02169.22199.32146.98-23.72176.5155.63129.07-9.2125.8131.2741.7422.2722.4825.8914.6027.2720.52-5.9940.6439.4014.8016.4112.317.65-14.73-3.997.2010.178.928.30
EPS Growth %-11.88%-15.1%35.61%719.65%-113.44%217.29%-56.9%1501.41%-135.68%-17.46%-25.08%87.43%-0.93%-13.17%77.33%-46.46%32.89%442.57%-114.74%3.15%166.22%-9.81%33.31%60.91%151.93%-269.17%-155.42%-29.2%14.01%7.47%34.96%
EPS (Basic)-169.74199.69147.32-23.72176.9255.67129.25-9.2125.8931.4141.9922.3822.5725.9614.6627.3120.54-5.9940.7340.4315.0516.7912.557.67-14.73-3.997.2710.419.208.58
Diluted Shares Outstanding12.45M12.73M13.04M13.38M13.58M13.8M13.82M13.88M13.92M14.01M14.08M14.06M14.06M12.59M9.76M9.73M9.78M9.83M9.81M9.98M9.96M9.99M10.08M10.03M9.85M8.53M6.92M5.64M5.63M5.65M5.63M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Social inflation casualty reserve pressure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Flattening Despite Volatile Quarters

Based on reported quarterly figures, Markel's revenue has oscillated between roughly $3.3B and $5.2B over the last ten quarters, with trailing top-line growth of -1.0% suggesting the premium base is no longer expanding meaningfully.

The sequential swings in revenue appear driven more by timing of premium recognition and Ventures activity than by a durable change in underwriting volume. A flat-to-slightly-declining trajectory is consistent with management's stated discipline of shrinking volume in softer pricing conditions rather than chasing share. Investors should monitor whether the next several quarters show renewed rate momentum or continued contraction, as the latter would weigh on float growth that underpins the holding company model.

Combined Ratio Swings Define Underwriting Profile

As reported in the quarterly income statement, Markel's combined ratio ranged from 70.8% to 107.7% across recent quarters, with the 2026Q1 print above 100% indicating an underwriting loss that required investment income to produce any profit.

The wide dispersion in combined ratio suggests catastrophe timing and reserve movements are contributing heavily to quarterly results rather than a steady underwriting run-rate. Loss ratios in the 30% to 55% band, which appear low relative to typical casualty-heavy books, may reflect favorable prior-year development or mix effects that warrant further investigation. Sustained readings above 100% would indicate the company is reliant on portfolio income to deliver earnings, a dependency investors should weigh against the reported net income figures.

Reserve Adequacy Questions Behind Earnings

Based on reported figures, the sharp drop in loss ratio during several quarters may partly reflect prior-year reserve releases, which would flatter current earnings if social inflation pressure on US casualty claims is not fully reflected in estimates.

Favorable development can mask weakness in current-year underwriting, and the reported volatility in loss ratios is consistent with this pattern. Given persistent social inflation in US casualty lines, reserve strengthening for older accident years remains a plausible future drag that is not yet visible in the reported numbers. Investors should track prior-year development disclosures closely, as these carry more information about true underwriting quality than headline combined ratios.

Net Income Driven by Equity Mark-to-Market

Net income in the reported quarters diverges sharply from operating income, with 2026Q1 showing an operating loss of $273.3M while the period's net result is also negative, and quarterly EPS swinging from -18.90 to 92.76 across the window.

Under current accounting rules, unrealized equity gains and losses flow through the income statement, making headline earnings a poor guide to operating health. The EPS volatility suggests the equity portfolio is contributing a large share of reported profit variance. Analysts should anchor on operating income and book value growth rather than quarterly net income when judging the investment engine.

Reported Earnings May Overstate Durability

The strongest challenge to Markel's reported earnings is that quarterly EPS of 92.76 in 2026Q2 and 59.25 in 2025Q3 appear to rely on favorable loss ratios and equity gains, which may not persist if casualty reserve development turns adverse.

If the lower loss ratios seen in some quarters reflect reserve releases rather than improved pricing, current profitability could be overstated relative to economic earnings. Equity-driven net income is inherently non-recurring and can reverse quickly, meaning the headline earnings trajectory may not indicate underlying franchise strength. Investors should weigh these possibilities before extrapolating recent profitability into forward valuation.

MKL — Frequently Asked Questions

Quick answers to the most common questions about buying MKL stock.

What was Markel Corporation's (MKL) revenue in 2025?

For fiscal year 2025, Markel Corporation (MKL) reported total revenue of $16.59B. This represents a 4423.9% increase compared to $366.7M in 1996.

Is Markel Corporation (MKL) profitable?

Markel Corporation (MKL) is profitable, generating $2.11B in net income for the fiscal year ending 2025 with a net profit margin of 12.7%.

What is Markel Corporation's operating profit margin?

Markel Corporation (MKL) reported an operating income of $2.73B, resulting in an operating profit margin of 16.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Markel Corporation's gross profit and gross margin?

Markel Corporation (MKL) generated $11.51B in gross profit for the year, representing a gross profit margin of 69.4%. This demonstrates the company's core pricing power and production efficiency.